Ni Qingqiang, Shen Weifeng, Zhang Minfeng, Yang Cheng, Cai Wenchang, Wu Mengchao, Yang Jiamei
Medical College of Soochow University, Suzhou, Jiangsu, China.
Department of Special Treatment and Liver Transplantation, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
Oncotarget. 2017 Jun 13;8(43):75627-75637. doi: 10.18632/oncotarget.18465. eCollection 2017 Sep 26.
The aim of this study was to investigate the relationship between the clinicopathological characteristics of intrahepatic cholangiocarcinoma (ICC) and both disease-free survival (DFS) and overall survival (OS) in intrahepatic cholangiocarcinoma (ICC) patients who underwent radical resection (R0). We retrospectively analyzed the clinicopathological characteristics of 319 patients who underwent radical resection of ICC between October 1999 and December 2003. The independent adverse prognostic factors that affected DFS after radical resection of ICC were as follows: maximum tumor diameter (HR = 1.330, = 0.014), complicated bile duct stone (HR = 1.923, = 0.013), macroscopic tumor thrombus (HR = 1.826, = 0.009), and lymph node metastasis (Pathology N1) (HR = 2.330, = 0.005) were independent adverse prognostic factors that affected the DFS after radical resection of ICC. The postoperative median DFS was 6 months. The independent adverse prognostic factors that affected OS after radical resection of ICC were as follows: maximum tumor diameter (HR = 1.326, = 0.014), complicated bile duct stone (HR = 2.349, = 0.001), and lymph node metastasis (Pathology N1) (HR = 2.420, = 0.003). The postoperative median survival time was 22 months, the 3-year survival rate was 33.9%, and the 5-year survival rate was 23.2%. Macroscopic tumor thrombus (OR = 2.991, = 0.004) was an independent risk factor for death within 1 year after radical resection.
本研究旨在探讨肝内胆管癌(ICC)患者接受根治性切除(R0)后,肝内胆管癌的临床病理特征与无病生存期(DFS)和总生存期(OS)之间的关系。我们回顾性分析了1999年10月至2003年12月期间接受ICC根治性切除的319例患者的临床病理特征。影响ICC根治性切除术后DFS的独立不良预后因素如下:肿瘤最大直径(HR = 1.330,P = 0.014)、合并胆管结石(HR = 1.923,P = 0.013)、肉眼可见肿瘤血栓(HR = 1.826,P = 0.009)以及淋巴结转移(病理N1)(HR = 2.330,P = 0.005)是影响ICC根治性切除术后DFS的独立不良预后因素。术后中位DFS为6个月。影响ICC根治性切除术后OS的独立不良预后因素如下:肿瘤最大直径(HR = 1.326,P = 0.014)、合并胆管结石(HR = 2.349,P = 0.001)以及淋巴结转移(病理N1)(HR = 2.420,P = 0.003)。术后中位生存时间为22个月,3年生存率为33.9%,5年生存率为23.2%。肉眼可见肿瘤血栓(OR = 2.991,P = 0.004)是根治性切除术后1年内死亡的独立危险因素。